腺相关病毒基因治疗后肝脏中污染质粒序列与载体基因组破坏
本文报告一例接受onasemnogene abeparvovec治疗后发生严重肝炎的1型脊髓性肌萎缩症患儿,对肝组织进行长读长和短读长宏基因组测序,发现具有复杂结构和重组的制造质粒序列、广泛破坏和串联化的载体基因组以及众多载体-人融合连接,并检出人β疱疹病毒6B。
要点
- 肝组织宏基因组测序检出复杂结构及重组的制造质粒序列
- 载体基因组广泛破坏、串联化并存在众多载体-人融合连接
- 肝脏中检出人β疱疹病毒6B
核心结论
- 需要进一步工作和研究更多患者,以确定制造质粒序列或辅助病毒的存在是否促成肝脏中这些复杂串联DNA结构的形成,以及这些是否是AAV基因治疗后肝毒性发生的因素。
研究设计与样本
- 病例研究:一名接受onasemnogene abeparvovec后发生严重肝炎的1型脊髓性肌萎缩症患儿,对肝组织进行长读长和短读长宏基因组测序。
主要发现
- 肝组织中发现具有复杂结构和重组的制造质粒序列。
- 载体基因组出现广泛破坏和串联化,并存在众多载体-人融合连接。
- 肝脏中检出人β疱疹病毒6B。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步工作和研究更多患者,以确定制造质粒序列或辅助病毒的存在是否促成肝脏中这些复杂串联DNA结构的形成,以及这些是否是AAV基因治疗后肝毒性发生的因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adeno-associated viruses (AAVs) are common vectors in gene therapy but can frequently cause liver complications in patients. The mechanisms underlying AAV-related liver toxicity remain poorly understood, posing challenges for effective prevention and intervention. Here we conducted a case study of a child with spinal muscular atrophy type 1 experiencing substantial hepatitis after receiving onasemnogene abeparvovec, undertaking long- and short-read metagenomic sequencing of liver tissue. We identified manufacturing plasmid sequences with complex structures and recombination. Vector genomes had extensive disruption and concatemerization as well as numerous vector-human fusion junctions. We also identified human betaherpesvirus 6B in the liver. Further work and investigation of more patients is needed to establish whether the presence of manufacturing plasmid sequences or helper viruses contribute to the formation of these complex concatemeric DNA structures in the liver, and whether these are a factor in the development of liver toxicity after AAV gene therapy.
引用
- Buddle S, Brown LK, Morfopoulou S, et al. Contaminating plasmid sequences and disrupted vector genomes in the liver following adeno-associated virus gene therapy. Nat Med. 2026. PMID: 41545588. doi:10.1038/s41591-025-04073-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。